A report by PricewaterhouseCoopers said employer spending on healthcare could increase anywhere from 4% to 10% next year. The report highlighted three potential scenarios depending on what happens with the Covid-19 pandemic.
This week, PricewaterhouseCoopers came out with a report on remaking primary care for what the consulting form called “the New Health Economy.” We would have covered it straight up on Wednesday, but a certain provider-focused health IT reporter at MedCity News was busy at the American Medical Informatics Association conference. Since it’s not breaking news […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The top sectors for corporate venture deals are software, energy and biotechnology, according to a new PwC and NCVA MoneyTree report.
Several biotechnology companies secured impressive venture funding this quarter, despite the fact that biotech investment is flat, a new PwC report shows.
Changes in the way healthcare is delivered, paid for and analyzed through big data, as well as the slow emergence of empowered patients, are creating a "modern-day gold rush," according to three strategic consultants at PricewaterhouseCoopers.
There's a growing sense of angst and frustration in the "data liberación" movement these days, and much of it has do with the difficulty of fighting the status quo in healthcare.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The vast majority of life sciences venture capital went to biotechnology, a PricewaterhouseCoopers report finds.
Bringing novel – and cost-effective – new drugs and devices to the market is the lifeblood of the life sciences industry, but it can’t do it without a symbiotic relationship with patients and regulators. PricewaterhouseCoopers just put out a new report that highlights the relationship between the Food and Drug Administration, the life sciences industry and consumers. Here’s what […]
Specialty drugs – the costly medications used to treat complex disease like cancer and Hepatitis C – have become a hot-button topic given the fact that healthcare spending is perpetually on the rise. After a five-year contraction in healthcare spending growth, medical costs are projected to climb another 6.8 percent in 2015, according to the Health […]